Multimodal analgesia in the treatment of a case of pediatric primary erythromelalgia with infection and pharmaceutical care

LI Mengqiu; ZUO Lei; RAN Xin; LI Qing; LI Xinyu; LUO Ning

doi:10.6039/j.issn.1001-0408.2024.13.19

您当前的位置：

首页 >

文章列表页 >

Multimodal analgesia in the treatment of a case of pediatric primary erythromelalgia with infection and pharmaceutical care

更新时间：2024-07-10

- Multimodal analgesia in the treatment of a case of pediatric primary erythromelalgia with infection and pharmaceutical care
- ZHONGGUO YAOFANG Vol. 35, Issue 13, Pages: 1658-1662(2024)
- 作者机构：
  
  1.重庆医科大学附属第一医院药学部，重庆　400016
  2.重庆医科大学附属第一医院疼痛科，重庆　400016
  3.江津区中心医院药学部，重庆　402260
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.13.19
  CLC： R969.3;R971+.3;R971+.6
- Published：15 July 2024，
  
  Received：11 January 2024，
  
  Revised：10 May 2024，
- 稿件说明：
扫描看全文
李梦秋,左蕾,冉鑫等.多模式镇痛治疗1例儿童原发性红斑性肢痛症伴感染并药学监护 ^Δ[J].中国药房,2024,35(13):1658-1662.

LI Mengqiu,ZUO Lei,RAN Xin,et al.Multimodal analgesia in the treatment of a case of pediatric primary erythromelalgia with infection and pharmaceutical care[J].ZHONGGUO YAOFANG,2024,35(13):1658-1662.
李梦秋,左蕾,冉鑫等.多模式镇痛治疗1例儿童原发性红斑性肢痛症伴感染并药学监护 ^Δ[J].中国药房,2024,35(13):1658-1662. DOI： 10.6039/j.issn.1001-0408.2024.13.19.

LI Mengqiu,ZUO Lei,RAN Xin,et al.Multimodal analgesia in the treatment of a case of pediatric primary erythromelalgia with infection and pharmaceutical care[J].ZHONGGUO YAOFANG,2024,35(13):1658-1662. DOI： 10.6039/j.issn.1001-0408.2024.13.19.

摘要

目的

对儿童原发性红斑性肢痛症探索以脊髓电刺激为基础的多模式镇痛方案，及多药联合治疗的药学监护要点。

方法

临床药师参与1例原发性红斑性肢痛症伴皮肤感染的患儿治疗过程，结合国内外文献，针对该患儿疾病治疗的难点制定多模式镇痛方案并进行药学监护。

结果

治疗团队针对该患儿采取以脊髓电刺激为基础的多模式镇痛治疗，包括不同镇痛药理靶点的多药联合、多种给药途径（口服、静脉、硬膜外、经皮）、多技术（脊髓电刺激、局部神经阻滞、患者自控镇痛）、辅助治疗的个体化方案，并监护用药的安全性。患儿住院及出院后随访期间双足疼痛得到了控制，创面愈合，无严重不良反应发生。

结论

以脊髓电刺激为基础的多模式镇痛是治疗儿童原发性红斑性肢痛症安全、有效的方式。

Abstract

OBJECTIVE

To explore a multimodal analgesia regimen based on spinal cord electrical stimulation for children with primary erythromelalgia and the key points of pharmaceutical care.

METHODS

Clinical pharmacists participated in the treatment of a child with primary erythromelalgia complicated with skin infection. After reviewing domestic and foreign literature， multimodal analgesia was formulated and pharmaceutical care was carried out to address the difficulties in treating the patient’s illness.

RESULTS

The treatment team applied multimodal analgesia based on spinal cord electrical stimulation for the child， including a multi-drug combination involving different analgesic pharmacological targets， multiple administration routes （oral， intravenous， epidural， percutaneous）， multiple technologies （spinal cord electrical stimulation， local nerve block， patient-controlled analgesia）， individualized schemes of adjuvant therapy， and the child was monitored for the safety of drug use. The pain was controlled during the treatment and follow-up period， the wound was healed， and no serious adverse drug reactions occurred.

CONCLUSIONS

Multimodal analgesia based on spinal cord electrical stimulation is a safe and effective treatment for children with primary erythromelalgia.

关键词

红斑性肢痛症脊髓电刺激多模式镇痛临床药师药学监护

Keywords

spinal cord electrical stimulationmultimodal analgesiaclinical pharmacistpharmaceutical care

references

CALDITO E G，KAUL S，CALDITO N G，et al. Erythromelalgia. part Ⅰ：pathogenesis，clinical features，evaluation，and complications[J]. J Am Acad Dermatol，2024，90（3）：453-462.

LEROUX M B. Erythromelalgia：a cutaneous manifestation of neuropathy[J]. An Bras Dermatol，2018，93（1）：86-94.

YANG Y，WANG Y，LI S，et al. Mutations in SCN9A，encoding a sodium channel alpha subunit，in patients with primary erythermalgia[J]. J Med Genet，2004，41（3）：171-174.

KIST A M，SAGAFOS D，RUSH A M，et al. SCN10A mutation in a patient with erythromelalgia enhances C-fiber activity dependent slowing[J]. PLoS One，2016，11（9）：e0161789.

KLEIN-WEIGEL P F，VOLZ T S，RICHTER J G. Erythromelalgia[J]. Vasa，2018，47（2）：91-97.

张倩，葛兰，宋志强. 红斑性肢痛症的诊治[J]. 临床皮肤科杂志，2021，50（6）：369-371.

ZHANG Q，GE L，SONG Z Q. Diagnosis and treatment of erythromelalgia[J]. J Clin Dermatol，2021，50（6）：369-371.

GRAZIOTTI P J，GOUCKE C R. Control of intractable pain in erythromelalgia by using spinal cord stimulation[J]. J Pain Symptom Manage，1993，8（7）：502-504.

FONTAINE D. Spinal cord stimulation for neuropathic pain[J]. Rev Neurol （Paris），2021，177（7）：838-842.

DEER T R，POPE J E，LAMER T J，et al. The neuromodulation appropriateness consensus committee on best practices for dorsal root ganglion stimulation[J]. Neuromodulation，2019，22（1）：1-35.

樊碧发，冯智英，顾柯，等. 脊髓电刺激治疗慢性疼痛专家共识[J]. 中国疼痛医学杂志，2021，27（6）：406-409.

FAN B F，FENG Z Y，GU K，et al. Expert consensus on spinal cord electrical stimulation in the treatment of chronic pain[J]. Chin J Pain Med，2021，27（6）：406-409.

PETERSEN E A，STAUSS T G，SCOWCROFT J A，et al. Effect of high-frequency （10-kHz） spinal cord stimulation in patients with painful diabetic neuropathy：a randomized clinical trial[J]. JAMA Neurol，2021，78（6）：687-698.

KAPURAL L，YU C，DOUST M W，et al. Novel 10-kHz high-frequency therapy （hf10 therapy） is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain：the senza-RCT rando- mized controlled trial[J]. Anesthesiology，2015，123（4）：851-860.

PATEL N，CHEN E，CUCCHIARO G. The complexity of pain management in patients with erythromelalgia[J]. A Case Rep，2015，5（9）：151-153.

IQBAL J，BHAT M I，CHAROO B A，et al. Experience with oral mexiletine in primary erythromelalgia in children[J]. Ann Saudi Med，2009，29（4）：316-318.

AL-MINSHAWY S M，EL-MAZARY A A. An Egyptian child with erythromelalgia responding to a new line of treatment：a case report and review of the literature[J]. J Med Case Rep，2014，8：69.

SAKAKIBARA R，FUKUTAKE T，KITA K，et al. Treatment of primary erythromelalgia with cyproheptadine[J]. J Auton Nerv Syst，1996，58（1/2）：121-122.

罗祎明，徐捷慧，易湛苗，等. 奥卡西平和卡马西平治疗原发性三叉神经痛的系统评价和荟萃分析[J]. 中国临床药理学杂志，2014，30（12）：1130-1134.

LUO Y M，XU J H，YI Z M，et al. Oxcarbazepine and carbamazepine in the treatment of primary trigeminal neuralgia：systemic review and meta-analysis[J]. Chin J Clin Pharmacol，2014，30（12）：1130-1134.

程韵霏，关巍. 抗癫痫药物卡马西平和奥卡西平肝脏毒性的比较[J]. 中国当代医药，2020，27（28）：171-174.

CHENG Y F，GUAN W. Comparison of liver toxicity of antiepileptic drugs carbamazepine and oxcarbazepine[J]. China Mod Med，2020，27（28）：171-174.

WHO. WHO guidelines approved by the guidelines review committee[M]. Geneva：World Health Organization，2012：1-25.

LI X Z，ZHOU M J，XIA Q，et al. Parecoxib sodium reduces the need for opioids after tonsillectomy in children：a double-blind placebo-controlled randomized clinical trial[J]. Can J Anesth，2016，63（3）：268-274.

TAN L N，TAYLOR E，HANNAM J A，et al. Pharmacokinetics and analgesic effectiveness of intravenous parecoxib for tonsillectomy ± adenoidectomy[J]. Paediatr Anaesth，2016，26（12）：1126-1135.

DUROSARO O，DAVIS M D P，HOOTEN W M，et al. Intervention for erythromelalgia，a chronic pain syndrome：comprehensive pain rehabilitation center，Mayo clinic[J]. Arch Dermatol，2008，144（12）：1578-1583.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Drug therapy analysis and care on a patient with Lemierre’s syndrome

Anti-infection treatment and pharmaceutical care for a patient with severe pneumonia caused by Chlamydia psittaci

Pharmaceutical practice of clinical pharmacist participation in a patient with Epstein-Barr virus encephalitis

Pharmaceutical care for a case of tumor patient with interstitial lung disease due to EGFR-TKI and AIDS opportunistic infection

Establishment of pharmaceutical care pathway based on the problems related to chemotherapy

Related Author

LIU Yusi

HUANG Lingfeng

HUANG Qinmiao

CAO Weiling

ZHANG Peng

LAI Zongqiang

LI Jun

SHANG Yongguang

Related Institution

Dept. of Respiratory Medicine， Shenzhen Luohu District People’s Hospital

Dept. of Pharmacy， Shenzhen Luohu District People’s Hospital

Dept. of Pharmacy， China-Japan Friendship Hospital

Dept. of Pharmacy， the Second Affiliated Hospital of Guangxi Medical University

Dept. of Pharmacy， Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰